Related references
Note: Only part of the references are listed.Lithium chloride reduced the level of oxidative stress in brains and serums of APP/PS1 double transgenic mice via the regulation of GSK3β/Nrf2/HO-1 pathway
Jie Xiang et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2020)
Glycogen synthase kinase-3 signaling in Alzheimer's disease
Elisabetta Lauretti et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)
Inula japonica ameliorated bleomycin-induced pulmonary fibrosis via inhibiting soluble epoxide hydrolase
Wen-Yu Zhao et al.
BIOORGANIC CHEMISTRY (2020)
Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease
Christian Grinan-Ferre et al.
NEUROTHERAPEUTICS (2020)
An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer's disease
Anamitra Ghosh et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Role of epoxy-fatty acids and epoxide hydrolases in the pathology of neuro-inflammation
Sean D. Kodani et al.
BIOCHIMIE (2019)
Soluble epoxide hydrolase modulates immune responses in activated astrocytes involving regulation of STAT3 activity
Chia-Chi Hung et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Lesion of the Locus Coeruleus Damages Learning and Memory Performance in Paraquat and Maneb-induced Mouse Parkinson's Disease Model
Liyan Hou et al.
NEUROSCIENCE (2019)
Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer's disease: Rational insights for the therapeutic approaches
Mir Hilal Ahmad et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2019)
Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer's disease
Hsueh-Te Lee et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of alpha-Synuclein Aggregation and ER Stress
Hui-Ju Huang et al.
MOLECULAR NEUROBIOLOGY (2018)
Whole-brain low-intensity pulsed ultrasound therapy markedly improves cognitive dysfunctions in mouse models of dementia - Crucial roles of endothelial nitric oxide synthase
Kumiko Eguchi et al.
BRAIN STIMULATION (2018)
Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammation
Weicang Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease
Qian Ren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Phloroglucinol ameliorates cognitive impairments by reducing the amyloid β peptide burden and pro-inflammatory cytokines in the hippocampus of 5XFAD mice
Eun-Jeong Yang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Epoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in GSK3β signaling
Bing-Qing Deng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates MPTP-Induced Parkinsonism
Xiaocui Qin et al.
MOLECULAR NEUROBIOLOGY (2015)
Genetic Variants of GSK3B are Associated with Biomarkers for Alzheimer's Disease and Cognitive Function
Petronella Kettunen et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases
Thomas Duflot et al.
EXPERT OPINION ON DRUG DISCOVERY (2014)
Inhibition of GSK3 beta-mediated BACE1 expression reduces Alzheimer-associated phenotypes
Philip T. T. Ly et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Jose Miguel Rubio-Perez et al.
SCIENTIFIC WORLD JOURNAL (2012)
The Clinical Problem of Symptomatic Alzheimer Disease and Mild Cognitive Impairment
Rawan Tarawneh et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Alzheimer's disease: synaptic dysfunction and Aβ
Ganesh M. Shankar et al.
MOLECULAR NEURODEGENERATION (2009)
Increased level of active GSK-3β in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration
K. Leroy et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2007)
Age-related changes in glycogen synthase kinase 3β (GSK3β) immunoreactivity in the central nervous system of rats
Soo Joo Lee et al.
NEUROSCIENCE LETTERS (2006)
Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation
H Kadowaki et al.
CELL DEATH AND DIFFERENTIATION (2005)
Glycogen synthase kinase-3β (GSK3β) binds to and promotes the actions of p53
P Watcharasit et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Comparison of vasodilatory properties of 14,15-EET analogs: structural requirements for dilation
JR Falck et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Evidence of oxidative damage in Alzheimer's disease brain:: central role for amyloid β-peptide
DA Butterfield et al.
TRENDS IN MOLECULAR MEDICINE (2001)
Epoxygenase pathways of arachidonic acid metabolism
DC Zeldin
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53's transcriptional activity
GA Turenne et al.
BMC CELL BIOLOGY (2001)
Share Paper
